The effect of varying practitioner communication on patients' health status and treatment outcomes by Verheul, William et al.
Title The effect of varying practitioner communication on patients' health
status and treatment outcomes
Author(s) Verheul, William; Mistiaen, Patriek; Di Blasi, Zelda; Kok, Louise; van
Dulmen, Sandra; Bensing, Jozien
Publication date 2010-10
Original citation Verheul W, Mistiaen P, Di Blasi Z, Kok L, van Dulmen S, Bensing J.
The effect of varying practitioner communication on patients’ health
status and treatment outcomes. Cochrane Database of Systematic
Reviews 2010, Issue 10. Art. No.: CD008791. DOI:
10.1002/14651858.CD008791.
Type of publication Article (peer-reviewed)
Link to publisher's
version
http://dx.doi.org/10.1002/14651858.CD008791
http://dx.doi.org/10.1002/14651858.CD008791
Access to the full text of the published version may require a
subscription.
Rights © 2010 The Cochrane Collaboration. Published by JohnWiley &
Sons, Ltd.  This review is published as a Cochrane Review in the
Cochrane Database of Systematic Reviews 2010, Issue 10. Cochrane
Reviews are regularly updated as new evidence emerges and in
response to comments and criticisms, and the Cochrane Database of
Systematic Reviews should be consulted for the most recent version
of the Review.
Item downloaded
from
http://hdl.handle.net/10468/251
Downloaded on 2017-02-12T05:11:48Z
The effect of varying practitioner communication on patients’
health status and treatment outcomes (Protocol)
Verheul W, Mistiaen P, Di Blasi Z, Kok L, van Dulmen S, Bensing J
This is a reprint of a Cochrane protocol, prepared and maintained by The Cochrane Collaboration and published in The Cochrane
Library 2010, Issue 10
http://www.thecochranelibrary.com
The effect of varying practitioner communication on patients’ health status and treatment outcomes (Protocol)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
13APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
16HISTORY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
16CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
16DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
16SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iThe effect of varying practitioner communication on patients’ health status and treatment outcomes (Protocol)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Protocol]
The effect of varying practitioner communication on patients’
health status and treatment outcomes
William Verheul1, Patriek Mistiaen1 , Zelda Di Blasi2, Louise Kok3, Sandra van Dulmen1, Jozien Bensing1
1NIVEL, Netherlands Institute for Health Services Research, Utrecht, Netherlands. 2Department of Applied Psychology, University
College Cork, Cork, Ireland. 3Faculty of Medicine, Utrecht University, Utrecht, Netherlands
Contact address: William Verheul, NIVEL, Netherlands Institute for Health Services Research, PO Box 1568, Utrecht, 3500 BN,
Netherlands. w.verheul@nivel.nl.
Editorial group: Cochrane Consumers and Communication Group.
Publication status and date: New, published in Issue 10, 2010.
Citation: Verheul W, Mistiaen P, Di Blasi Z, Kok L, van Dulmen S, Bensing J. The effect of varying practitioner communication on
patients’ health status and treatment outcomes. Cochrane Database of Systematic Reviews 2010, Issue 10. Art. No.: CD008791. DOI:
10.1002/14651858.CD008791.
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the effects of interventions in which healthcare practitioner communication in face-to-face consultations with patients is
experimentally varied in comparison to usual care or contrasted active control interventions, on patient health and treatment outcomes.
A secondary aim is to investigate if the intervention effect is modified by intervention type, type of illness, length of follow-up, type of
outcome and the way the subjects are exposed to communication in studies (real versus simulated).
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B A C K G R O U N D
Communication between practitioners and patients lies at the
heart of medicine, accompanying almost every step in health care
(de Haes 2009). Communication is pivotal in establishing diag-
noses and treatment plans, and inherent in giving advice and deal-
ing with the patient’s emotional reactions to the implications of
disease. Nevertheless communication was, for a long time, taken
for granted. In the last few decades, however,medical communica-
tion is increasingly addressed in the literature. Studies on patient-
practitioner communication are often performed within theoreti-
cal frameworks. These include Roger’s client-centred theory or the
framework of patient-centred care (Bensing 2000; Bensing 2003);
the biopsychosocial model (Engel 1988); and relationship-ori-
ented care (Roter 2006) which all advocate an approach that does
take patients, and not only their biomedical problems, into ac-
count. These are now favoured models for physician-patient com-
munication because they connect to current ethical views on the
physician-patient relationship and they also seem to be associated
with beneficial patient outcomes (Michie 2003; Stewart 2000).
However, the ideological base of communication in medicine
seems more developed than its evidence base (Bensing 2000; de
Haes 2009).
Intervention studies assessing the effects of manipulating health-
care practitioner-patient communication within these frameworks
are often very complex. Furthermore such studies are few, lack
methodological rigor or fail to specify the mechanisms through
which communication influences outcomes (Griffin 2004). In-
stead, communication is used as a ’container concept’, keeping us
in the dark as to how it can be used as a tool to help reach desired
outcomes.
In order to extend the evidence base of the effects of specified
communication elements onpatients, firstly potentialmechanisms
which can explain the influence of certain communication be-
haviours on patient outcomes should be defined, secondly these
mechanisms should be operationalized in observable behaviours
and thirdly these behaviours should be systematically varied in
controlled experiments (de Haes 2009). In the proposed review
we will seek to identify studies that do so in face-to-face patient-
practitioner communication, with a focus on patients’ health and
treatment outcomes.
Practitioner-patient communication has to fulfil diverse criteria
in order to be successful. In a systematic review (Di Blasi 2001),
Di Blasi and colleagues used Leventhal’s self-regulation theory
(Cameron 2003) to explain how a person, threatened by signs and
symptoms of illness, responds with cognitive and emotional reac-
tions to a practitioner’s communication. In consultations, health-
care practitioners influence the way patients think and feel about
their illness or treatment. Di Blasi 2001 classified interventions
into those varying either (or both) cognitive or emotional care
by means of communication. Cognitive care aims to influence
patients’ expectations about the illness or the treatment, whereas
emotional care refers to the style of the consultation (e.g. warm,
empathic), and aims to reduce negative feelings such as anxiety
and fear. Di Blasi 2001 found that patient-practitioner commu-
nication interventions using a combination of cognitive care and
emotional care affected patients’ health outcomes. Other reviews
found similar results (Beck 2002; Griffin 2004).This closely con-
nects to what Engel 1988 called the patient’s double need: a need
to know and understand, and a need to feel known and under-
stood. For both needs, practitioner-patient communication has
been shown to play an important role (Bensing 1992). The need
to know and understand is a cognitive need for which cognitive
care is important; this is achieved by communication targeting
the transfer of information, such as the doctor telling the patient
what is happening with their body and what they can expect. The
second need is an emotional need for which emotional care is im-
portant. Emotional care is communication targeted at establishing
a good therapeutic relationship between healthcare practitioner
and patient. Examples are eye contact, empathic statements and
leaving room for patients to tell their stories.
It is important to note that the difference between communication
providing cognitive care and emotional care is not always clear-cut.
For example, if a doctor tells a patient “I’m so relieved to tell you
that your test results are all OK”, the information offered about
the test results is of an instrumental nature, while the expression
of relief is affect-oriented. Nevertheless there is considerable ev-
idence that such a distinction can be made in practice and that
this distinction is useful in the sense that the amount of affect-
oriented communication is related to patient outcomes (Bensing
1992;Hall 1987). The distinction between affect-oriented and in-
strumental communication is not alwaysmade, however, and their
relative contribution has not been thoroughly assessed. For exam-
ple, Kaptchuk 2008 found that healthcare practitioner commu-
nication with extra attention, warmth and confidence decreased
problems in patients with irritable bowel syndrome in comparison
to a control group in which the practitioner did not ’augment’ the
communication. However the extent to which these effects were
the result of emotional care compared with cognitive care is un-
clear. This review will focus on disentangling these components
of communication and will assess their separate and combined ef-
fects on patient outcomes.
Description of the intervention
We will review interventions which vary practitioner communi-
cation with patients. ’Communication’ is defined as verbal and
non-verbal interaction. We will only include studies in which the
communication occurs face-to-face. By varying communication
we refer to experimental manipulation of one or more elements
in patient-practitioner communication. The manipulation might
be to vary only a single sentence (for example, a doctor might
say that a treatment will certainly have a positive effect, compared
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with saying that the treatment might or might not work) or to
vary a practitioner’s overall communication style (such as warm
and friendly versus cold and formal).
As explained, communication canbe classified as cognitive or emo-
tional care or both; we will use these concepts throughout the re-
view. Interventions in which the practitioner varies communica-
tion in terms of providing information about diagnosis, treatment
and consequences for the patient will be classified as cognitive care.
When communication is aimed at changing patients’ emotions,
for example by variations in the friendliness, trust, empathy or
optimism conveyed, we will classify the intervention as emotional
care. Communication providing information alongside optimism
would be classified as both cognitive and emotional care (Di Blasi
2001).We have listed several examples of the intervention in Table
1.
Table 1. Examples of the intervention
Study Themanner in which communica-
tion was varied
Main outcomes Cognitive or emotional care
Fogarty 1999 Breast cancer consultation with or
without physician’s statements of
empathy
Patients’ anxiety Emotional
Gryll 1978 Dental patients were treated by a
warm or neutral practitioner and
practitioners raised positive, uncer-
tain or no expectations regarding the
effectiveness of sham-medication on
tension, anxiety and sensitivity on
pain.
Pain and anxiety Cognitive and emotional
Kaptchuk 2008 Practitioner administering acupunc-
ture to patients with irritable bowel
syndrome (IBS) with or with-
out extra communication conveying
warmth, attention, and confidence
Change in IBS-symptoms Cognitive and emotional
Rose 1993 Non-cardiac chest pain patients were
administered a provocative agent by
a physician who told that the intra-
venous medication was given to ob-
serve changes in the tracing or that it
would elicit their usual pain.
Elicited pain Cognitive
Thomas 1987 GP giving a clear diagnosis and rais-
ing positive recovery expectations
versus giving no clear diagnosis and
uncertain expectations about recov-
ery
Patients’ speed of recovery Cognitive
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How the intervention might work
To establish how varying communication in the patient-practi-
tioner relationship can influence patients’ health outcomes, we
need to look at the possible mechanisms involved. The division
into cognitive and emotional care is a start. Different kinds of
communication can lead to different cognitive responses (e.g. out-
come expectancies) and emotional responses (e.g. stress), which in
turn can directly or indirectly affect patients’ health.
Research and theory on the placebo effect can guide us as to how
cognitive and emotional care conveyed by communication can
lead to changes in patients’ health or treatment outcomes (Di Blasi
2001). Patients’ responses are not only due to inherent character-
istics of a certain treatment, such as the pain-relieving effect of an
analgesic, but also to a range of unspecified factors. Placebo effects,
sometimes called context effects, are effects on a patient’s health
caused by nonspecific factors of a treatment. This definition has a
limited durability: once factors and their effects are specified, they
are removed from the scope of this definition. Patient-practitioner
communication is such a factor which is often left unspecified.
While there are numerous studies assessing the specific effects of a
certain pharmaceutical, surgical or other medical intervention, the
effects of patient-practitioner communication on patients’ health-
related outcomes have received far less attention (Crow 1999; de
Haes 2009; Di Blasi 2001; Griffin 2004). By making placebo ef-
fects and their causal factors an object of research, instead of some-
thing that needs to be controlled for in trials, our understand-
ing of placebo effects’ mechanisms has grown (Benedetti 2008;
Harrington 1999). These mechanisms can help us understand the
effects of patient practitioner communication on health-related
outcomes.
Research on the placebo effect suggests that there are three im-
portant mechanisms involved: expectancy manipulation (Crow
1999; Di Blasi 2001; Kong 2007; Price 2008), conditioning (Price
2008; Benedetti 2003) and affect manipulation (Di Blasi 2001;
Klossika 2006; Lieberman 2004; Price 2008; Staud 2004; Vase
2005; Villemure 2002).
Expectancy manipulation
Expectancies are cognitions, which can be manipulated by in-
formation and suggestion about medical procedures, treatment
and the management of illness. The change in patients’ self-effi-
cacy and outcome expectations can lead to positive and negative
health outcomes (Crow 1999). The direct effect of influencing
patients’ expectations on outcomes such as physiological status or
pain has been extensively documented, perhaps most clearly in
the field of pain research where an expectation of pain relief has
been found to activate neurological systems involved in regulat-
ing pain (Price 2008). Studies have shown that where pain relief
or anti-anxiety medication was administered by hidden compared
with open means, their effectiveness was dramatically reduced.
This highlights the importance of practitioner communication
(Colloca 2004), as practitioners can influence patients’ expectan-
cies by means of their communication.
Conditioning
Placebo effects can also be attained by classical conditioning, es-
pecially when effects are not consciously experienced (such as hor-
mone secretion (Benedetti 2003) or immuno-suppression (Ader
2003)). Conditioning occurs when a stimulus (such as a health-
care practitioner communicating in a certain way) coincides with
an effect (such as recovery). A laboratory example of conditioning
with health effects is provided in a study where subjects repeatedly
consume a coloured drink containing an immunosuppressant, af-
ter which drinking an inert coloured drink will lead to immuno-
suppression (Goebel 2002). This means that previous experiences
of patients not only shape their conscious expectations, but also
can lead to conditioned responses. With regard to communication
in the patient-practitioner relationship, this means that commu-
nication which matches patients’ earlier experiences can act as a
conditioned stimulus and elicit the same effects on health as effects
which coincided with those earlier experiences.
Affect manipulation
Changes in negative affect or stress can have a direct influence
on health status. For example, anxiety reduction can lead to pos-
itive health effects by mediation through decreased sympathetic
activation (Drummond 2001). Neuroscientific research also offers
clues that context effects on pain are influenced by negative affect
(Benedetti 2007; Lieberman 2004; Vase 2005) by showing the ac-
tivation of brain areas involved. Negative affect can also slow down
wound healing (Vileikyte 2007). One could argue that reduction
of negative affect is a mere by-product of positive expectations,
but changes in negative affect can also be caused by a practitioner’s
emotional care. Such effects can be either beneficial (for example
by being empathic) or detrimental (for example by acting in a
rushed manner). Furthermore, a healthcare practitioner can be an
important source of support when a person is confronted with an
illness. The importance of social support and its relation to health
outcomes is thoroughly established (Cacioppo 2003). Other ex-
amples of decreasing negative affect and/or increasing positive af-
fect in patients is by increasing their trust (McKinstry 2006; Rosser
2001), hope (Clayton 2008; Schmid Mast 2005) and confidence
(Thomas 1987), for instance by a practitioner’s increased warmth
(Kaptchuk 2008) or empathy (Fogarty 1999).
Apart from direct effects, cognitive and emotional care provided
through communication can influence patients’ health and quality
of life outcomes by many mediating factors, including improve-
ments in adherence to treatment plans (Robinson 2008), self-care,
patient knowledge, patient understanding, patient empowerment,
patient agency, the quality ofmedical decisions and emotional self-
management, and attenuated negative social influences (Epstein
2007).
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Why it is important to do this review
Di Blasi 2001 reviewed the influence of contextual interventions
related to the patient-practitioner relationship on patients’ health
outcomes. Other systematic reviews have sought studies in which
the communication in the patient-practitioner relationship was
manipulated, but their search or selection criteria were limited
(Beck 2002; Stewart 1995) or their scope was narrower (Beck
2002; Crow 1999; Griffin 2004). LikeDi Blasi 2001, Griffin 2004
concluded that there are few well-designed trials with communi-
cation-related contextual interventions. Di Blasi and colleagues’
overall conclusion was that a warm, friendly, reassuring communi-
cation style showed the most consistent positive effect on patients’
health outcomes. Griffin and colleagues found that interventions
increasing patient participation, providing specific information
about a disease and giving attention to emotion, showed the most
promise in terms of promoting patients’ health. However, most
studies assessing the effects of manipulating practitioner-patient
communication are very complex, or lack methodological rigor.
Usually the trials do not specify the mechanisms through which
communication influences outcomes. There is much heterogene-
ity in populations (such as setting, and patients’ health problems)
and the interaction with individual differences and demographic
variables such as cultural context is unknown. In Di Blasi 2001 all
of the 25 included studies were conducted in Europe and North
America.Wehope to identify relevant studies fromother locations,
in order to provide amore culturally-comprehensive review of how
practitioner communication can influence patient outcomes.
Some studies (Ellington 2008; Fogarty 1999) have tried to tackle
the complexity and ethical problems of researching the effects of
varying communication, for instance by simulating amedical con-
sultation by showing a video or using healthy subjects in a role-
played medical situation. It is important to take such studies into
account, because they allow a very high level of experimental con-
trol, and thus diminish the influence of confounding factors. Also,
it might not be ethical to assign possibly vulnerable patients re-
ceiving actual medical care to, for instance, an unfriendly practi-
tioner or practitioner raising negative outcome expectations. This
is likely to be unpleasant for patients and might be detrimental
to their health outcomes. However, the possibility that such ’neg-
ative’ behaviours can have an effect on patient outcomes means
they deserve further study. By using simulations it is possible to
circumvent the ethical issues. Such simulations can indeed have
an effect on some outcomes. A classic study using video simu-
lation is Fogarty 1999 on breast cancer consultations. The same
consultation was shown to all participants, but in the intervention
group 40 seconds of empathic statements was incorporated in the
healthcare practitioner’s communication, resulting in significantly
less anxiety amongst intervention group participants. Of course,
the external validity of such studies has to be taken into account: it
might be that in an actual clinical situation, patients will respond
differently than in a simulation. However the added experimen-
tal control and the possibility of studying ethically-sensitive vari-
ations in communication through simulation studies might help
this complex field to move forward.
We plan to conduct an extended follow up on Di Blasi 2001. The
interventions in the 25 trials included in Di Blasi’s review were
targeted at cognitive care or a mix of cognitive and emotional
care. No trials in which only emotional care was manipulated were
found. Our review hopes to provide new knowledge about how
patient-practitioner communication can be used to beneficially
influence patients’ health outcomes. A decade of communication
research (both Di Blasi 2001 and Griffin 2004 searched up to
1999) is likely to have producedmore well-designed trials assessing
the effects of varying communication in the patient-practitioner
relationship. The questions we want to answer in this review are:
1. What is the effect of varying communication in the patient-
practitioner relationship on patients’ health or health status?
2. Which kinds of communication interventions lead to
changes in those outcomes?
O B J E C T I V E S
To assess the effects of interventions in which healthcare practi-
tioner communication in face-to-face consultations with patients
is experimentally varied in comparison to usual care or contrasted
active control interventions, on patient health and treatment out-
comes.
A secondary aim is to investigate if the intervention effect is modi-
fied by intervention type, type of illness, length of follow-up, type
of outcome and the way the subjects are exposed to communica-
tion in studies (real versus simulated).
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include randomised and quasi-randomised controlled tri-
als.
We will exclude controlled before-and-after studies, interrupted
time series studies, and all non-experimental studies, because of
their higher risk of bias. We will not exclude studies on the basis of
allocation concealment or blinding (Higgins 2008; Ryan 2007a).
Types of participants
Participants aged over 12 years involved in face-to-face communi-
cation with a healthcare practitioner (e.g. physician, nurse, allied
staff ).
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We will exclude studies of people with drug addiction, intellectual
disability (people with a considerably lower than average intelli-
gence combined with an inability to adapt to everyday life with-
out help), or psychotic symptoms, because social functioning in
these groups is probably markedly different than in other patient
groups. We will also exclude studies in which participants use a
translator to communicate with the healthcare practitioner, be-
cause the communication is influenced by the translator.
Types of interventions
Interventions in which face-to-face communication with a health-
care practitioner was manipulated. We will include simulation
studies in which videos of patient-provider communication are
shown to patients, or where healthy subjects were used instead of
patients.
Intervention groups will be compared to usual care or other con-
trasted intervention groups (active control interventions).
We will exclude:
• interventions conducted via telephone, email or websites, as
it is likely that such media change the dynamics of
communication, for instance because many or all aspects of non-
verbal communication are absent.
• interventions in which only biomedical treatment
characteristics are varied, such as size and shape of medication.
• talking-therapy interventions such as psychotherapy,
because in these the communication is the complete treatment
rather than part of the context.
Types of outcome measures
Primary outcomes
Our primary outcome measures will be patients’ physical and psy-
chological health status, and treatment outcomes. The selected
outcomes are described according to theCochraneConsumers and
Communication Review Group’s taxonomy of relevant outcomes
(Outcomes 2008). We will use the following subdivisions of this
taxonomy to categorize outcomes: physical health, psychological
health, psychosocial outcomes, adverse outcomes, clinical assess-
ments, pain assessment or control and physiological measures.
We will exclude studies that do not report at least one of the
primary outcomes. Any disagreement about whether or not study
outcomes can be classified as primary outcomes for this review will
be resolved by discussion among review authors.
Health Status
This outcome category includes:
• level of activities of daily living,
• level of dependency,
• self-care abilities,
• self efficacy,
• level of anxiety, depression, mood,
• well being,
• quality of life,
• self-esteem,
• level of confidence, and
• psychological or psycho-physiological stress.
Treatment Outcomes
This outcome category includes:
• complications,
• complication rate,
• need for medical intervention,
• morbidity,
• mortality,
• relapse,
• side effects of drugs,
• clinical assessments (e.g. wound healing, symptom
resolution),
• pain assessment or control (e.g. use of medications or other
means to reduce pain), and
• physiological measures (e.g. blood pressure, cell counts,
blood glucose level).
Secondary outcomes
Secondary outcome measures will be all other reported consumer-
oriented outcomes, for instance:
• adherence to treatment (self-reported adherence, refill rate),
• perceptions of coping,
• family functioning,
• social activity,
• recall of information.
Secondary outcomes do not form part of the criteria for including
studies in this review. An extended list of these outcomes is avail-
able at Outcomes 2008 under the following subheadings: knowl-
edge and understanding; communication; patient involvement in
care process; evaluation of care, support; skills acquisition; health
behavior.
Timing of outcome assessment
Wewill only include studies in which the first outcome assessment
took place within one month after completion of the interven-
tion, because effects of these interventions seem improbable after
a longer period of time.
Search methods for identification of studies
Searching for relevant studies is challenging because of the absence
of a common terminology for interventions in which communi-
cation in the patient-practitioner relationship is varied. Studies
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are scattered along different strains of research focused on mecha-
nisms of the placebo effect, patient-provider communication and
psychological variables in medical care, making it difficult to de-
velop a search strategy that is sufficiently sensitive and precise.
Our search strategy is adapted from the search used by Di Blasi
2001. The rationale for the search strategy is described below. The
PubMed search strategy is given in Appendix 1 and will be adapted
for other databases.
The search strategy will consist of nine concepts, relating to dif-
ferent components of standard search strategies (derived from the
standard PICO components: Participant or Population, Interven-
tion, Comparison and Outcome): patients, the practitioner, com-
munication, suggestion, patient-practitioner communication, rel-
evant psychological constructs, the placebo effect, placebos and
outcome assessment. We include sensitive filters to identify ran-
domised controlled trials (Higgins 2008) and systematic reviews
(Shojania 2001).
Electronic searches
We will search the following electronic databases from their start
date to the present:
• Consumers and Communication Review Group Specialised
Register
• The Cochrane Central Register of Controlled Trials
(CENTRAL, The Cochrane Library)
• EMBASE through Embase.com
• PubMed (incorporating MEDLINE and Old MEDLINE)
• PsycINFO
• CINAHL
• LILACS
• Controlled-trials.com
• ProQuest Dissertations & Theses (PQDT) database
• OpenSIGLE
• Sociological Abstracts
We will conduct a forward citation search in the following
databases:
• Social Sciences Citation Index
• Sciences Citation Index
We will not restrict our searches in terms of the language in which
studies are published or conducted, although the choice of elec-
tronic databases to be searched is a possible source of bias. We
chose to search LILACS in order to find relevant Latin American
and Caribbean reports. Search terms will be in English, whichmay
be a source of bias if reports are not properly indexed with English
search terms. We will take this into account in the discussion of
possible bias in the review.
Searching other resources
We will seek relevant reviews and will examine all studies included
in these reviews (backward search).We will also examine all studies
citing these reviews (forward search), using the (Social) Sciences
Citation Index. We will not conduct handsearches. Where possi-
ble we will contact authors of included studies to identify other
potentially-relevant studies.
Data collection and analysis
Selection of studies
Given that we anticipate a large number of search results, all au-
thors will be involved in the selection process, managed by WV
and PM. Non-English language reports will be translated if nec-
essary.
Phase 1
1.1 We will conduct the search for relevant reviews.
1.2 We will combine search results into a single database and
remove duplicates.
1.3 We will screen titles and abstracts to remove obviously irrele-
vant reviews. Five per cent of the search output (up to 1000 items)
will be screened by multiple authors to assess inter-rater reliabil-
ity. If the percentage agreement is below 0.95, reasons for dis-
agreement will be analysed and discussed to prevent further dis-
agreement. This method is repeated until agreement above 0.95
is reached. Subsequently, titles and abstract will be screened by
one rater per report (using multiple raters). Reviews of interest are
reviews which potentially or actually include studies which meet
the review’s inclusion criteria (see also Appendix 2).
1.4 If all criteria are met or when it is unclear if all criteria are met,
we will obtain the review in full text for further examination.
1.5 The reviews meeting all criteria form the set of reviews of
interest.
1.6 We will add all studies referred to in these reviews to the
database of potentially-eligible studies (backward search).
1.7Wewill conduct a forward search for studies citing the relevant
reviews, and add these studies to the database of potentially-eligible
studies.
Phase 2
2 We will conduct the search for RCTs and quasi-RCTs.
Phase 3
3.1 We will combine the results from phases 1 and 2 into a Ref-
Works database and remove duplicate records.
3.2 We will screen the studies in the database against the review’s
inclusion criteria (see also Appendix 2). If all criteria are met or
when it is unclear if all criteria are met, reports are included in the
next stage of selection.
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3.3Wewill retrieve potentially-relevant reports in full text and two
authors will examine them independently for eligibility against the
inclusion criteria (see also Appendix 3). In case of disagreement
or doubt, a third author will arbitrate. If necessary information is
missing we will contact the study authors to seek clarification.
3.4 We will scan the reference lists of included studies. Any pos-
sibly-relevant studies identified in this way are re-entered at step
3.1 and if not previously examined, screened on title and abstract
and, if necessary, full text.
3.5 We will link multiple reports of the same study using all rele-
vant information.
Studies excluded at any stage will be retained in a database. Any
apparently relevant studies excluded on full text review will be
listed in the table Characteristics of Excluded Studies in the review.
Data extraction and management
Using a data extraction form based on the Cochrane Consumers
andCommunicationReviewGroup’s data extraction template and
the template used in Di Blasi 2001, we will extract the following
information from included studies:
1. General information: title, authors, source, publication
status, date published, language.
2. Study methods: aims of intervention, aim of study, study
design, methods of participant recruitment, inclusion/exclusion
criteria, informed consent and ethical approval, funding.
3. Risk of bias: see Assessment of risk of bias in included
studies.
4. Patients: description, geographic location, setting, number,
age, gender, ethnicity, socioeconomic status distribution,
principal health problem or diagnosis, stage of illness, treatment
received.
5. Providers: description (GP, specialist physician, nurse,
physical therapist, etc), geographic location, setting, age, gender.
6. Interventions: description (which communication aspects
are varied), frequency, timing, duration, purpose, initiator,
details of control/usual or routine care, co-interventions.
7. Outcomes: principal and secondary outcomes as specified,
methods of assessing outcomes, follow up for non-respondents,
timing of outcome assessment, adverse events.
8. Results: for outcomes and times of assessment, control and
intervention groups.
Two review authors will independently extract full descriptions
of the interventions onto a standard form. The standard forms
will then be checked by a third review author for discrepancies. If
discrepancies between the two review authors’ data extraction exist,
then those will be discussed by the data extractors and other review
authors until discrepancies are resolved. In the case of missing
data, we will try to contact the authors of the studies to obtain the
information.
Assessment of risk of bias in included studies
We will assess and report on the risk of bias in included stud-
ies in accordance with the guidelines of the Cochrane Con-
sumers and Communication Review Group (Ryan 2007) and
the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2008).
We will assess sequence generation, allocation concealment, blind-
ing of participants, providers and outcome assessors, incomplete
outcome data, selective outcome reporting and other sources of
bias for RCTs and quasi-RCTs (Higgins 2008).
Two review authors will asses the risk of bias independently. Dis-
agreements will be resolved in a team discussion. We will use a
scoring sheet to assess bias and categorize studies for described
sources of bias as having a low risk of bias, a high risk of bias or
an uncertain risk of bias in the following categories: selection bias,
performance bias, attrition bias, detection bias and other sources
of bias (Ryan 2007). These forms of bias in the included studies
will be assessed using the checklist provided by theCochrane Con-
sumers and Communication Review Group (Ryan 2007). We will
contact study authors if necessary to obtain missing information.
The risk of bias information will be in tables in the review. We
will not provide overall quality scores to divide studies in into high
and low quality (Herbison 2006). Instead we will address risk of
bias by sensitivity analysis.
Measures of treatment effect
We will report standardised mean differences (SMDs) for contin-
uous outcomes and risk ratios (RR) for dichotomous outcomes
(Deeks 2001).
Unit of analysis issues
For cluster-randomised trials, repeated measurements or stud-
ies with more than two intervention groups, we will appropri-
ately handle any unit-of-analysis issues, adhering to guidelines in
Higgins 2008 if possible. More specifically, we will extract effect
sizes from cluster-randomised trials if the analysis accounted for
clustering. If not or if it is unclear, we will consult a statistician. For
repeated measurements, we will use the measurement closest to
the intervention to maximize available data (in studies in Di Blasi
2001measurement often took place directly after the intervention;
see also Subgroup analysis and investigation of heterogeneity).
Dealing with missing data
Where data are missing, wewill try to obtain these data from study
authors. The number screened, eligible and randomised patients
will be examined.When outcome data aremissing, for instance be-
cause of drop-outs, losses to follow-up and participant withdrawal,
we will assess the risk of bias in accordance with Ryan 2007 and
Higgins 2008. The numbers as well as the reasons for incomplete
data will be reported. To this end, we will contact study authors if
necessary.
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Assessment of heterogeneity
If clinical, methodological or statistical heterogeneity is large, we
will not combine study results in quantitative meta-analysis. We
will assess heterogeneity by inspection of the forest plots. Hetero-
geneity will be quantified using I2 and interpreted according to
Higgins 2008. Subgroup analyses will be undertaken to investigate
heterogeneity, as outlined in Subgroup analysis and investigation
of heterogeneity below.
Assessment of reporting biases
We will use funnel plots to assess reporting biases. Funnel plot
asymmetry will be tested statistically when 10 ormore studies with
a continuous outcome or 10 or more studies with a dichotomous
outcome are included (Higgins 2008). We will use a test based on
linear regression of intervention effect estimates for continuous
outcomes (Tang 2000) and dichotomous outcomes (Peters 2006).
If funnel plot asymmetry exists, we will discuss its possible causes
(Higgins 2008).
Data synthesis
Wewill provide a narrative overview of the included studies, struc-
tured according to similarity of interventions. We will list the
exact communication behaviours which are varied. We will de-
scribe interventions as aimed at cognitive or emotional care, ana-
logue or real patients, and provide the sample characteristics (also
see Subgroup analysis and investigation of heterogeneity). Sam-
ple characteristics that will be used to structure the reporting of
interventions, but are not mentioned under subgroup analysis,
are variations in the gender and age of subjects or practitioners
and the type of practitioner. Gender and age influences how pa-
tients and practitioners communicate, as well as how they perceive
each other’s communication (DeVoe 2009; Roter 2002). Types of
healthcare practitioner can differ in communication style, avail-
able time for communication, and perceived status. This might
impact the effects of interventions: for example, nurses generally
have more time per patient compared to physicians. We will also
address type of practitioner, because interventions seem to include
physicians more often than other types of practitioners. We will
also describe possible working mechanisms (expectancymanipula-
tion, conditioning, affect manipulation; see Background).We will
report the direction, size, consistency, strength of evidence of the
effects of interventions and possible effect modifiers in included
studies in tables. We will use graphs and box plots where we deem
those will improve clarity of presentation.
The decision whether to perform a quantitative meta-analysis will
be made after completion of the search, selection and extraction
process. This decision will be based on homogeneity/heterogene-
ity of interventions and outcomes in the included studies. If a
quantitative meta-analysis is undertaken, we will pool SMDs for
continuous outcomes and RRs for dichotomous outcomes using
random effect meta-analysis. In both cases we will report confi-
dence intervals. Statistical analysis will be performed according to
the Cochrane Handbook (Higgins 2008) using Review Manager
5 software.
Subgroup analysis and investigation of heterogeneity
If there are at least two trials from each subgroup, we will examine
subgroups according to type. We will not analyse subsets of par-
ticipants within studies because reports of studies seldom contain
sufficient detail (Higgins 2008). Hence when more than one sub-
group type is included in the study, we will not include it in the
subgroup analysis. We will draw a distinction between ’qualitative
interaction’ (differences in the direction of the effect) and ’quanti-
tative interaction’ (differences in the size of the effect but not the
direction) (Higgins 2008; Yusuf 1991). The subgroup analyses will
be carried out with a random effects meta-regression model using
the ’Metareg’ macro with Stata. We will use P values of regression
coefficients of dummy variables indicating subgroup to determine
if statistically significant differences between subgroups exist. If
significant effects exist, the regression coefficients will be used to
investigate how the subgroups potentially affect the intervention
estimate (Higgins 2008).
We will conduct the following subgroup analyses:
• Interventions targeting subjects’ emotions, cognitions or
both, since these may set off different mechanisms (see
Background).
• The type of illness: patient’s illness might enhance or limit
the effectiveness of communication interventions. For example,
non-specific low back pain might be more easily influenced than
cancer-related pain, and acute irritable bowels might be more
easily influenced than chronic irritable bowel syndrome
(Harrington 1999). We will thus differentiate types of illness on
both the specific illness and its chronicity. We will identify
groups based on the International Statistical Classification of
Diseases and Related Health Problems (WHO 2007). We will
include a mixed group for mixed populations (e.g. patients in
general practice). If information about duration is reported, we
will differentiate between acute and chronic illnesses. We define
an illness as chronic if the duration is equal or greater than six
months.
• Studies of real versus simulated communication between
patient and practitioner (see Background).
• Subgroup analysis for different outcomes: certain outcomes
might be more easily influenced than others. For example,
placebo effects on pain have been quite extensively documented,
but influences on such outcomes as wound healing seem much
less likely (Harrington 1999). Categorisation of outcomes will
occur using the Cochrane Consumers and Communication
Review Group’s taxonomy of relevant outcomes (Outcomes
2008), in which the following subdivisions are made: physical
health, psychological health, psychosocial outcomes, adverse
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outcomes, clinical assessments, pain assessment or control and
physiological measures.
• We will also take into account differences in interval
between intervention and outcome assessment. It is possible that
many communication interventions have an effect which is
diluted by other variables influencing the patient in everyday life.
We will group studies measuring outcomes directly after the
intervention (within one hour), more than 1 hour but within 24
hours after the intervention and more than 24 hours after the
intervention. In case of repeated observations for several periods
of follow up, we will perform separate analyses for outcomes
measured at different times (Higgins 2008).
Other subgroups are of interest, but we are cautious about per-
forming more subgroup analyses, as finding from multiple sub-
groups might be misleading (Higgins 2008). Subgroup analyses
are observational by nature and are not based on randomised com-
parisons. The likelihood of false negative and false positive signif-
icance tests increases rapidly as more subgroup analyses are per-
formed. We will therefore not perform more subgroup analyses,
but we will present and discuss other subgroup characteristics in
included studies without performing tests as described under Data
synthesis.We will take care not to generate misleading recommen-
dations by addressing possible misinterpretations of subgroup re-
sults.
Sensitivity analysis
If possible from the data sets, we will conduct multiple sensitivity
analyses across the seven domains of risk of bias in which we will
exclude studies with inadequate sequence generation, allocation
concealment, blinding of participants, providers and outcome as-
sessors, incomplete outcome data, selective outcome reporting or
other sources of bias for RCTs and quasi-RCTs (see Assessment of
risk of bias in included studies). We will perform separate sensitiv-
ity analyses excluding studies with high risk on a certain domain
of risk of bias and we will also perform a sensitivity analysis that
includes only trials deemed to be at a low or unclear risk of bias
across the seven domains. During the review process individual
peculiarities of the studies under investigation might be identified
as suitable for sensitivity analysis, if so, we will carry out extra
sensitivity analysis.
Consumer participation
We will report on the involvement of consumers in the design and
implementation of each included study. The review protocol was
discussed with four consumers (two patients and two practition-
ers) and their feedback was implemented in the final version of
this protocol. These consumers were asked to pay attention to the
applicability of interventions in clinical practice, both in a prac-
tical and an ethical sense. We intend to do so again in the dis-
cussion of the results. We will present our results to a consumer
panel (consisting of both patients and practitioners who will be
recruited after a first draft of the review is ready) in order to receive
feedback for implementation of interventions or development of
new interventions. As reported in several studies, patient-practi-
tioner communication is a pivotal element of medical care for con-
sumers. The results of this review could be used by consumers to
inform themselves about the most adequate communication styles
in medical care and use this as a measure of comparison for their
care. Consumer organisations could use the review’s findings to
lobby for more attention to proper patient-practitioner commu-
nication as an element of care not only influencing patient satis-
faction, but also health status.
Dissemination plans
In addition to publication in the Cochrane Database of System-
atic Reviews, we aim to publish the review in a leading peer-re-
viewed medical journal. The review will also be published within
the contact author’s PhD thesis. We aim to present the findings
of the proposed review at conferences and meetings for medical
professionals, researchers and consumers. We also aim to publish
a translation of the review in a Dutch medical journal.
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Appendix 1. PubMed search strategy
Medline AND Old-Medline through PubMed
#1. PATIENTS
(patient[MeSH] OR patient OR patients OR subject OR subjects OR participant* OR client* OR inpatient* OR outpatient* OR
hospitalized* OR institutionalized* OR survivor*)
#2. PROVIDERS
(health personnel[MeSH] OR doctor* OR physician* OR provider* OR practitioner* OR gp OR gps OR health professional*OR
nurse* OR carer* OR caregiver* OR clinician* OR health care professional* OR healthcare professional* OR health care worker* OR
dentist* OR anaesthetist* OR anesthetist* OR midwi* OR hospitalist* NOT (veterinarian*))
#3. COMMUNICATION
(communication[MeSH] OR interact* OR communicat* OR relation* OR instruct* OR verbal* OR nonverbal OR smiling OR “facial
expression” OR advis* OR Counsel* OR talk* OR contact* OR conversation* OR consult OR consultation)
#4. SUGGESTION
(suggestion[MeSH] OR suggest* OR frame* OR framing* OR label* )
#5. PATIENT-PROVIDER INTERACTION
(“Professional-Patient Relations”[MeSH] OR “Patient-Centered Care”[MeSH] OR “Physician’s Role”[MeSH] OR “nurse’s
role”[MeSH] OR “Professional Patient” OR “patient professional” OR therapeutic alliance OR “doctor-patient” OR “patient-doctor”
OR “clinician-patient” OR “patient-clinician” OR “physician-patient” OR “patient-physician” OR “nurse-patient” OR “patient-nurse”
OR “patient-practitioner” OR “practitioner-patient” OR patient-centered OR patient-centred OR patient-focused OR patient-
focussed OR person-centered OR person-centred OR biopsychosocial*)
#6. RELEVANT PSYCHOLOGICAL CONSTRUCTS
(“set (psychology)”[MeSH] OR “self concept”[MesH] OR anticipat* OR hope* OR expectanc* OR expectation* OR expect OR ex-
pected OR faith* OR wish* OR desir* OR (doubt* OR disbelie* ORmistrust* OR skeptic* OR sceptic* OR (attitude* AND (positive
OR negative)) OR belief*[tiab] OR empath* OR compassion* OR warm OR warmly OR warmth OR friendly OR enthusias* OR
humanistic OR attentive*) OR (trust* NOT (nhs*trust[tiab] OR service*trust[tiab] OR hospital*trust[tiab] OR research*trust[tiab]
OR welcome?trust[tiab] OR centre?trust[tiab] OR heritage*trust[tiab] OR teaching*trust[tiab] OR community*trust[tiab] OR uni-
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versity*trust[tiab] OR healthcare*trust[tiab] OR trust*fund[tiab] OR trustees[tiab] OR health*trust[tiab] OR wellcome*trust[tiab]
OR trust*headquarters[tiab] OR health*care*trust[tiab])) OR “anxiety”[MeSH] OR fear* OR “anxiety”[all fields] OR “anxious”[All
Fields] OR stress[tiab] OR stressed OR negative-affect OR positive-affect OR relax* OR “conditioning (psychology)”[MeSH] OR
conditioning OR conditioned)
#7. PLACEBO EFFECT
(Placebo effect[MeSH] OR context-action*[All Fields] OR contextual-action*[All Fields] OR context-effect*[All Fields] OR contex-
tual-effect*[All Fields] OR context-influence*[All Fields] OR contextual-influence*[All Fields] OR context-intervention*[All Fields]
OR contextual-intervention*[All Fields] OR context-response*[All Fields] OR contextual-response*[All Fields] OR context-result*[All
Fields] OR contextual-result*[All Fields] OR nocebo-action*[All Fields] OR nocebo-effect*[All Fields] OR nocebo-influence*[All
Fields] OR nocebo-intervention*[All Fields] OR nocebo-response*[All Fields] OR nocebo-result*[All Fields] OR non-drug-action*[All
Fields] OR non-drug-effect*[All Fields] OR non-drug-influence*[All Fields] OR non-drug-intervention*[All Fields] OR non-drug-re-
sponse*[All Fields] OR non-drug-result*[All Fields] OR nonpharmacological-action*[All Fields] OR non-pharmacological-action*[All
Fields]ORnonpharmacological-effect*[All Fields]ORnon-pharmacological-effect*[All Fields]ORnonpharmacological-influence*[All
Fields] OR non-pharmacological-influence*[All Fields] OR nonpharmacological-intervention*[All Fields] OR non-pharmacological-
intervention*[All Fields] OR nonpharmacological-response*[All Fields] OR non-pharmacological-response*[All Fields] OR nonphar-
macological-result*[All Fields] OR non-pharmacological-result*[All Fields] OR nonspecific-action*[All Fields] OR non-specific-ac-
tion*[All Fields] OR nonspecific-effect*[All Fields] OR non-specific-effect*[All Fields] OR nonspecific-influence*[All Fields] OR non-
specific-influence*[All Fields] OR nonspecific-intervention*[All Fields] OR non-specific-intervention*[All Fields] OR nonspecific-re-
sponse*[All Fields] OR non-specific-response*[All Fields] OR nonspecific-result*[All Fields] OR non-specific-result*[All Fields] OR
placebo-action*[All Fields] OR placebo-effect*[All Fields] OR placebo-influence*[All Fields] OR placebo-intervention*[All Fields]
OR placebo-response*[All Fields] OR placebo-result*[All Fields] OR situational-action*[All Fields] OR situational-effect*[All Fields]
OR situational-influence*[All Fields] OR situational-intervention*[All Fields] OR situational-response*[All Fields] OR situational-
result*[All Fields])
#8. PLACEBOS
(Placebos[MeSH] OR placebo effect[MeSH] OR placebo* OR nocebo)
#9. OUTCOME ASSESMENT
(“Outcome AND Process Assessment (Health Care)”[MeSH])
#10. FILTER FOR IDENTIFYING RANDOMIZED CONTROLLED TRIALS
(randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized [tiab] OR placebo [tiab] OR drug therapy [sh] OR
randomly [tiab] OR trial [tiab] OR groups [tiab]) NOT (animals[mh] NOT (animals[mh] AND humans [mh]))
#11. SYSTEMATIC REVIEW FILTER
((meta-analysis [pt] ORmeta-analysis [tw] ORmetanalysis [tw]) OR ((review [pt] OR guideline [pt] OR consensus [ti] OR guideline*
[ti] OR literature [ti] OR overview [ti] OR review [ti]) AND ((Cochrane [tw] OR Medline [tw] OR CINAHL [tw] OR (National
[tw] AND Library [tw])) OR (handsearch* [tw] OR search* [tw] OR searching [tw]) AND (hand [tw] OR manual [tw] OR electronic
[tw] OR bibliographi* [tw] OR database* OR (Cochrane [tw] OR Medline [tw] OR CINAHL [tw] OR (National [tw] AND Library
[tw]))))) OR ((synthesis [ti] OR overview [ti] OR review [ti] OR survey [ti]) AND (systematic [ti] OR critical [ti] OR methodologic
[ti] OR quantitative [ti] OR qualitative [ti] OR literature [ti] OR evidence [ti] OR evidence-based [ti]))) BUTNOT (case* [ti] OR
report [ti] OR editorial [pt] OR comment [pt] OR letter [pt])
Search A:Studies on Patient-provider interaction (5) involving suggestion (4), relevant psychological constructs (6), placebo effects (7),
placebos (8), OR outcome assessment (9).
#12 Combined as: ((#5 OR (1 AND 2 AND 3)) AND (#4 OR #6 OR #7 OR #8 OR #9)).
Search B:Studies on suggestive communication (4) in a clinical setting (1 AND 2) involving relevant psychological constructs (6).
#13 Combined as: (#1 AND #2 AND #4 AND #6).
Search C:Studies on Placebo effect(7) involving relevant psychological concepts(6) OR suggestion(4)
#14 Combined as: (#7 AND (#4 OR #6)).
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COMPLETE SEARCH for REVIEWS: (#12 OR #13 OR #14) AND #11
COMPLETE SEARCH for RCTs: (#12 OR #13 OR #14) AND #10
Appendix 2. Form for screening study reports on title and abstract
1. Reviewed by: WV ZDB JB SvD PM LK
2. Full reference:
3. Criteria:
I. Communication in the patient-practitioner interaction is varied No Not sure Yes
II. Study is a randomized controlled trial or a quasi randomized
trial
No Not sure Yes
III. Study conducted on not mentally disabled, non psychiatric,
non drug addict sample, age > 12 years
No Not sure Yes
IV. Outcome is physical, psychological or psychosocial health sta-
tus or treatment outcome
No Not sure Yes
4. Recommendations:
I. If any of the boxes are ticked ‘No’: Exclude
II. If all boxes are ticked ‘Not sure’ OR Yes’: Preliminary include
Note: If you tick any of the criteria as ‘No’, do not continue to check the other criteria: exclude and move on to the next title & abstract
Help:
I. There is a face-to-face communication between a patient and practitioners and this communication is varied. Not psychotherapy
II. There is a control or comparison group and subjects are randomly or quasi randomly allocated to intervention or control/comparison
groups
IV. See outcome list for specified outcomes
Appendix 3. Form for screening full text reports of studies
1. Reviewed by: WV ZDB JB SvD PM LK
2. Full reference:
3. Criteria:
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(Continued)
I. Communication in the patient-practitioner interaction is varied No Not sure Yes
II. Study is a randomized controlled trial or a quasi randomized
trial
No Not sure Yes
III. Study conducted on not mentally disabled, non psychiatric,
non drug addict sample, age > 12 years
No Not sure Yes
IV. Outcome is physical, psychological or psychosocial health sta-
tus or treatment outcome
No Not sure Yes
4. Recommendations:
I. If any of the boxes are ticked ‘No’: Exclude
II. If any of the boxes are ticked ‘Not sure’: Discuss (AND/OR)
Request info from study authors
III. If all boxes are ticked Yes’: Include
Summary and outcome of review authors’ discussion:
Additional information request to study authors study authors:
H I S T O R Y
Protocol first published: Issue 10, 2010
C O N T R I B U T I O N S O F A U T H O R S
JB and WV conceived the idea for this review. WV wrote a first draft of the protocol. ZDB contributed by providing ideas, comments
and documents of her earlier review. WV and PM developed the search strategies, which were reviewed by all other authors. PM, JB,
ZDB, SvD & LK all commented on drafts of the protocol. WV wrote the final version which was approved by all co-authors.
D E C L A R A T I O N S O F I N T E R E S T
WV, JB and SvD have been involved in the design, conduct or publication of potentially eligible studies for this Cochrane review.
These authors will not be involved in the assessment of these studies for inclusion in the review, nor in their data extraction if they are
included.
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